Agenda

    NDA HTA SEMINAR – THE FUTURE OF HEALTH TECHNOLOGY ASSESSMENT IN EUROPE

    starts:24/10/2018 ends:24/10/2018 from:8:30 to:12:00 address:Medicon Valley Alliance, Arne Jacobsens Alle 15 , Ørestad City, Copenhagen, Ground floor mobile:+45 6141 8634 email: nm@mva.org www: Link >> Import to calendar
    adresse:
    Medicon Valley Alliance, Arne Jacobsens Alle 15 , Ørestad City, Copenhagen, Ground floor
    Get directions

    Venue: Medicon Valley Alliance, Arne Jacobsens Alle 15 , Ørestad City, Copenhagen, Ground floor

    Date: 24/10/2018

    Time: 8:30 - 12:00

    On the 24th October NDA Group invites you and your colleagues in the market access department/HEOR to a complimentary seminar on the future of HTA.

    The market access environment is getting increasingly challenging. The ability to develop plans and strategies for access, for today as well as tomorrow, is critical to bring new medicines to patients.

    With 17 years as Executive Director for NICE, Carole Longson has unparalleled experience in understanding how HTA bodies work and collaborate in the EU. In June 2018 she joined NDA as a HTA Advisor.

    This seminar will discuss the past, present and future of HTA and market access. On stage Carole is joined by an esteemed panel comprising Dr Steffen Thirstrup, former Division Head at the Danish Medicines Agency and CHMP member, Dr Fredrik Andersson, Senior Director Global HEOR Ferring and Mark Aalgren, Senior Director Market Access and Public Affairs ALK.

    If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

    Copyright 2018 Danskbiotek. All rights reserved.